I might be completely off base but from my understanding discussions had at the recent strategic update briefings, RC330 was heading down the path of being a wearable injectable not an oral formulation. Take this as hearsay and not official company direction.
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-22
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.000(0.00%) |
Mkt cap ! $258.9M | |||
| Open | High | Low | Value | Volume |
| $1.53 | $1.55 | $1.52 | $28.98K | 19.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 689 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 1386 | 2 |
View Market Depth
| Last trade - 11.45am 20/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |